» Articles » PMID: 39837396

The Levels of the Long Noncoding RNA MALAT1 Affect Cell Viability and Modulate TDP-43 Binding to MRNA in the Nucleus

Overview
Journal J Biol Chem
Date 2025 Jan 21
PMID 39837396
Authors
Affiliations
Soon will be listed here.
Abstract

TAR DNA-binding protein (TDP-43) and metastasis-associated lung adenocarcinoma transcript (MALAT1) RNA are both abundantly expressed in the human cell nucleus. Increased interaction of TDP-43 and MALAT1, as well as dysregulation of TDP-43 function, was previously identified in brain samples from patients with neurodegenerative disease compared to healthy brain tissues. We hypothesized that TDP-43 function may depend in part on MALAT1 expression levels. Here, we find that alterations in MALAT1 expression affect cell viability and can modulate TDP-43 binding to other mRNAs in HEK293 and SH-SY5Y human cell lines. Disruption of either MALAT1 or TDP-43 expression induces cell death, indicating that both macromolecules contribute positively to survival. Depletion of MALAT1 RNA results in increased binding of TDP-43 to other mRNA transcripts at the 3' UTR. Finally, we examined the contribution of MALAT1 expression to survival in a cell culture model of neurodegeneration using MPP treatment in SH-SY5Y cells. Depletion of MALAT1 RNA protects against toxicity in a cellular model of neurodegeneration and modulates TDP-43 binding to mRNA transcripts involved in apoptotic cell death. Taken together, we find that MALAT1 RNA and TDP-43 interactions can affect mRNA levels and cell viability. A tightly regulated network of noncoding RNA, messenger RNA, and protein interactions could provide a mechanism to maintain appropriate RNA expression levels and contribute to neuronal function.

References
1.
Bernard D, Prasanth K, Tripathi V, Colasse S, Nakamura T, Xuan Z . A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression. EMBO J. 2010; 29(18):3082-93. PMC: 2944070. DOI: 10.1038/emboj.2010.199. View

2.
Hallegger M, Chakrabarti A, Lee F, Lee B, Amalietti A, Odeh H . TDP-43 condensation properties specify its RNA-binding and regulatory repertoire. Cell. 2021; 184(18):4680-4696.e22. PMC: 8445024. DOI: 10.1016/j.cell.2021.07.018. View

3.
Perez D, Gil C, Martinez A . Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases. Med Res Rev. 2010; 31(6):924-54. DOI: 10.1002/med.20207. View

4.
Smith T, Heger A, Sudbery I . UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy. Genome Res. 2017; 27(3):491-499. PMC: 5340976. DOI: 10.1101/gr.209601.116. View

5.
Liu B, Wang X, Cao J, Chen L, Wang Y, Zhao B . TDP-43 upregulates lipid metabolism modulator ABHD2 to suppress apoptosis in hepatocellular carcinoma. Commun Biol. 2022; 5(1):816. PMC: 9376094. DOI: 10.1038/s42003-022-03788-w. View